Safety and Immunogenicity of a Recombinant Tetanus Vaccine in Healthy Adults in China: A Randomized, Double-Blind, Dose Escalation, Placebo- and Positive-Controlled, Phase 1/2 Trial.
Xu X, Yu R, Xiao L, Wang J, Yu M, Xu J, Tan Y, Ma X, Wu X, Lian J, Huang K, Ouyang X, Bi S, Wu S, Wang X, Jin J, Yu L, Zhang H, Wei Q, Shi J, Chen W, Li L.
Xu X, et al. Among authors: yu l, yu m, yu r.
Adv Sci (Weinh). 2021 Aug;8(15):e2002751. doi: 10.1002/advs.202002751. Epub 2021 Jun 3.
Adv Sci (Weinh). 2021.
PMID: 34081408
Free PMC article.
Clinical Trial.